ChengDa Pharmaceuticals Co. Ltd. (301201) — Financial Flexibility Index
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Financial Flexibility Index of 1.08x as of December 2024. Free cash flow of CN¥315.01 Million (operating CF CN¥28.65 Million minus capex CN¥286.36 Million) represents 1% of total liabilities (CN¥290.77 Million). Check ChengDa Pharmaceuticals Co. Ltd. (301201) asset resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ChengDa Pharmaceuticals Co. Ltd. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for ChengDa Pharmaceuticals Co. Ltd. across 6 annual periods. See 301201 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ChengDa Pharmaceuticals Co. Ltd. (2019–2024)
Year-by-year free cash flow to debt coverage for ChengDa Pharmaceuticals Co. Ltd.. For the full company profile including market capitalisation, see ChengDa Pharmaceuticals Co. Ltd. stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.08x | CN¥315.01 Million | CN¥28.65 Million | CN¥290.77 Million | ▼ -54.1% |
| 2023 | 2.36x | CN¥416.74 Million | CN¥192.07 Million | CN¥176.40 Million | ▼ -1.3% |
| 2022 | 2.39x | CN¥253.36 Million | CN¥47.67 Million | CN¥105.81 Million | ▲ +65.5% |
| 2021 | 1.45x | CN¥221.84 Million | CN¥83.14 Million | CN¥153.30 Million | ▼ -43.5% |
| 2020 | 2.56x | CN¥192.78 Million | CN¥128.97 Million | CN¥75.30 Million | ▲ +308.5% |
| 2019 | 0.63x | CN¥118.59 Million | CN¥67.52 Million | CN¥189.21 Million | — |